Doximity co-founder Dr. Nathan Gross steps down as CSO, stays as advisor

Doximity, Inc.

Dr. Gross transitions from Chief Strategy Officer to advisor effective June 16, 2025.
No cash compensation for advisory role; RSU & option awards continue vesting through September 2025.
Gross co-founded Doximity in 2010 and served as CSO; advisory agreement filed later.
Blog post from CEO Tangney thanks Gross for 15 years; Gross cites 'bittersweet' decision.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Nathan Gross

Chief Strategy Officer

DOCS · Doximity, Inc.

Effective: 2025-06-16
Filed: June 13, 2025, 7:59 PM ET

On June 10, 2025, Dr. Nathan Gross notified Doximity, Inc. (the “Company”) that he will step down from his role as Chief Strategy Officer to become an advisor to the Company, effective June 16, 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Nathan Gross changed role as Chief Strategy Officer at Doximity, Inc..

Action: step down
Role: Chief Strategy Officer

Exact text from the filing

On June 10, 2025, Dr. Nathan Gross notified Doximity, Inc. (the “Company”) that he will step down from his role as Chief Strategy Officer to become an advisor to the Company, effective June 16, 2025.

View on SEC.gov

Doximity, Inc. filing history →

Source: SEC EDGAR

accession 0001516513-25-000065

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.